Skip to content

Mayo Clinic Precure - Prospective Study

Mayo Clinic Precure - Prospective Study

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07332598
Enrollment
100000
Registered
2026-01-12
Start date
2026-01-19
Completion date
2035-12-01
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exposure, Environmental, Genetic Predisposition

Brief summary

The goal of this observational study is to 1) better understand and predict biological processes before disease begins or is identified, 2) study genomic and environmental contributors to disease, 3) identify ways to stop disease advancement before it becomes serious or complex, and 4) identify potential targets for disease therapy. Participants will be asked to: * collect biological samples, * download a mobile app, * collect speech (voice) recordings, and * complete surveys

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 years * Registered Mayo Clinic patient * Able to provide informed written consent * Able to receive mail and packages within a United States (US) state * Able to collect and ship samples within a US state via FedEx for overnight delivery

Exclusion criteria

* Active hematological cancer or history of a hematological cancer * Allogeneic Bone Marrow Transplant (autologous bone marrow transplant recipients are acceptable if collected at least one month after transplant) * Other co-morbidity that, in physician's opinion, would interfere with patient's ability to participate in the study (e.g., reduced ability to comprehend, i.e., dementia, intellectual disability, etc.)

Design outcomes

Primary

MeasureTime frame
Build a comprehensive, multi-omics and phenotype datasetUp to 5 years

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKonstantinos N. Lazaridis, M.D.

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026